Similar to Tregs, myeloid-derived suppressor cells (MDSC) do not have a direct anti-tumor effect, but they reduce arginine amino acid, nitric oxide synthase and interleukin-2 (IL-2) levels by expressing arginine I in effector T cells [17]. Here, IL2 is linked to neoplasm.